About Aurinia (AUPH)
Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in pa... Read more
- USD4.91
- USD4.96
- USD4.71
- USD12.43
- -5.00%
- 237M
- 2.10M
- 1.31M
- 738M
- 4.85
- -54.40%
Stock News
1 hour ago
A 'deeply misguided' political belief is weakening the economy, says Secretary of Commerce Gina Raimondo
CNBC
1 hour ago
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo
1 hour ago
13 Best Low Volatility Stocks to Buy According to Hedge Funds
Yahoo
1 hour ago
Procter & Gamble's strategic pricing shift should accelerate business growth this year
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
